Oncolytics Biotech Inc T.ONC

The list of potential of Buyers

[SundayMovies]

Someone from this list will buy out ONCY:

https://www.oncolyticsbiotech.com/clinical-trials/collaborators

[Noteable]

Two maor partners Pfizer, Merck KGaA are the only ones mentioned in co-development with ONCY.

[Noteable]

December 22, 2022 - Pfizer takes an equity stake in ORIC Pharmaceuticals now giving the biotech enough cash to run operations through the first half of 2025 thanks to a $25 million equity investment and a new clinical partnership with Pfizer.   The pharma giant will work with the therapeutic resistance-focused biotech on ORIC-533, an oral small molecule inhibitor of CD73 in phase 2

[Noteable]

Further to Pfizer's support of ORIC Pharmaceutical's CD73 inhibitor, recent studies demonstrated that the combination of intratumoral oncolytic reovirus, followed by targeted blockade of Programmed cell death protein 1 (PD-1) checkpoint inhibition and/or the immunomodulatory CD73/Adenosine system can enhance anti-tumor immunity, making ONCY's oncolytic virus pelareorep a logical

[Noteable]

As noted in an earlier posting ONCY's pelareorep down regulates HIF-1alpha, which is a sigificant inducer of TME hypoxia, as well as a down-regulator of the enzyme adenosine, which is a potent TME immunosuppressant, thus making ONCY's pelareorep a logical acquisition target for Pfizer.

[itntdf]

although i don't believe they are a buyout candidate, adlai is also a development partner: Development Plan. As soon as reasonably practicable after the Effective Date, the Parties shall, acting through the JSC in accordance with the provisions of Clause 2, agree on and finalize the Development Plan, which shall focus on the development of Licensed Products